Journal of Hazardous Materials Advances · Nov 2026

Perfluorobutyric acid induces premature senescence in human lung fibroblasts with altered RNA m¹A regulators and proteomic remodeling

By Lin R, Su J, Tan L et al.

We report that perfluorobutyric acid (PFBA), a novel short-chain alternative to long-chain per- and polyfluoroalkyl substances (PFAS), induces premature senescence in human lung fibroblasts, revealing a previously unrecognized pulmonary senescence effect and underscoring the urgent need to reassess its mechanisms of action and safety. Short-term repeated exposure to PFBA at 40.0, 178.0, or 356.0 μmol/L for 7 days caused pronounced premature senescence relative to untreated controls, accompanied by increased senescence-associated β-galactosidase activity, cell cycle arrest, elevated intracellular reactive oxygen species, and a dysregulated senescence-associated secretory phenotype. RT-qPCR and western blotting revealed disrupted expression of enzymes and proteins in the RNA N1-methyladenosine (m1A) regulatory machinery. Proteomics and TRMT61B-based RIP-qPCR further identified imbalanced expression of premature senescence-related target proteins. At higher PFBA exposure levels, the expression of TRMT61B and TRMT10C was significantly increased, whereas ALKBH3 and YTHDC1/YTHDFs were decreased. These premature senescence-associated alterations were closely linked to oxidative phosphorylation and cellular senescence pathways. Notably, the binding of TRMT61B to target RNAs (IL6, FOXO1, and TFAM) was markedly altered. PFBA treatment reduced TRMT61B binding to IL6 and TFAM while upregulating IL6 mRNA expression. Collectively, these findings demonstrate that PFBA induces a pronounced premature senescence phenotype in human lung cells, remodels the RNA m¹A methylation regulatory machinery, and alters target gene expression through the TRMT61B axis, closely linking PFBA exposure to aging and age-related diseases. This work provides reliable laboratory evidence to support health risk assessment of PFBA and offers new insights into the pathogenesis, prevention, and intervention of aging-related diseases.

doi.org/10.1016/j.hazadv.2026.101744Open accessMechanisms

AgingResearch.News